This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wakabayashi, H.
Right arrow Articles by Yamaguchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakabayashi, H.
Right arrow Articles by Yamaguchi, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 1998, p. 1587-1591, Vol. 42, No. 7
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Inhibition of Hyphal Growth of Azole-Resistant Strains of Candida albicans by Triazole Antifungal Agents in the Presence of Lactoferrin-Related Compounds

Hiroyuki Wakabayashi,1,* Shigeru Abe,2 Susumu Teraguchi,1 Hirotoshi Hayasawa,1 and Hideyo Yamaguchi2

Nutritional Science Laboratory, Morinaga Milk Industry Co., Ltd., Zama, Kanagawa 228-8583,1 and Department of Microbiology and Immunology, Teikyo University School of Medicine, Itabashi-ku, Tokyo 173-8605,2 Japan

Received 8 September 1997/Returned for modification 27 January 1998/Accepted 13 April 1998

The effects of bovine lactoferrin (LF) or the LF-derived antimicrobial peptide lactoferricin B (LFcin B) on the growth of Candida albicans hyphae, including those of three azole-resistant strains, were investigated by a crystal violet staining method. The hyphae of two highly azole-resistant strains were more susceptible to inhibition by LF or LFcin B than the azole-susceptible strains tested. One moderately azole-resistant strain was defective in the formation of hyphae and showed a susceptibility to LF greater than that of the susceptible strains but a susceptibility to LFcin B similar to that of the susceptible strains. The highly azole-resistant strain TIMM3317 showed trailing growth in the presence of fluconazole or itraconazole, while the extent of growth was reduced by the addition of LF or LFcin B at a sub-MIC. Thus, the addition of LF or LFcin B at a sub-MIC resulted in a substantial decrease in the MICs of fluconazole and itraconazole for two highly azole-resistant strains; e.g., the MIC of fluconazole for TIMM3317 was shifted from >256 to 0.25 µg/ml by LF, but the MICs were not decreased for the susceptible strains. The combination effects observed with triazoles and LF-related compounds in the case of the two highly azole-resistant strains were confirmed to be synergistic by the fractional inhibitory concentration index. These results demonstrate that for some azole-resistant C. albicans strains, LF-related compounds combined with triazoles can inhibit the growth of hyphae, an important form of this organism in pathogenesis.


* Corresponding author. Mailing address: Nutritional Science Laboratory, Morinaga Milk Industry Co., Ltd., 5-1-83 Higashihara, Zama, Kanagawa 228-8583, Japan. Phone: 81-462-52-3045. Fax: 81-462-52-3049.


Antimicrobial Agents and Chemotherapy, July 1998, p. 1587-1591, Vol. 42, No. 7
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kitamura, A., Higuchi, S., Hata, M., Kawakami, K., Yoshida, K., Namba, K., Nakajima, R. (2009). Effect of {beta}-1,6-Glucan Inhibitors on the Invasion Process of Candida albicans: Potential Mechanism of Their In Vivo Efficacy. Antimicrob. Agents Chemother. 53: 3963-3971 [Abstract] [Full Text]  
  • Wakabayashi, H., Yamauchi, K., Kobayashi, T., Yaeshima, T., Iwatsuki, K., Yoshie, H. (2009). Inhibitory Effects of Lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob. Agents Chemother. 53: 3308-3316 [Abstract] [Full Text]  
  • Noverr, M. C., Huffnagle, G. B. (2004). Regulation of Candida albicans Morphogenesis by Fatty Acid Metabolites. Infect. Immun. 72: 6206-6210 [Abstract] [Full Text]  
  • Takakura, N., Wakabayashi, H., Ishibashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S. (2004). Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 53: 495-500 [Abstract] [Full Text]  
  • Takakura, N., Wakabayashi, H., Ishibashi, H., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S. (2003). Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice. Antimicrob. Agents Chemother. 47: 2619-2623 [Abstract] [Full Text]  
  • Lupetti, A., Paulusma-Annema, A., Welling, M. M., Dogterom-Ballering, H., Brouwer, C. P. J. M., Senesi, S., van Dissel, J. T., Nibbering, P. H. (2003). Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species. Antimicrob. Agents Chemother. 47: 262-267 [Abstract] [Full Text]  
  • Wakabayashi, H., Uchida, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., Yamaguchi, H. (2000). Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J Antimicrob Chemother 46: 595-602 [Abstract] [Full Text]  
  • McLain, N., Ascanio, R., Baker, C., Strohaver, R. A., Dolan, J. W. (2000). Undecylenic Acid Inhibits Morphogenesis of Candida albicans. Antimicrob. Agents Chemother. 44: 2873-2875 [Abstract] [Full Text]  
  • Oh, H., Hedberg, M., Wade, D., Edlund, C. (2000). Activities of Synthetic Hybrid Peptides against Anaerobic Bacteria: Aspects of Methodology and Stability. Antimicrob. Agents Chemother. 44: 68-72 [Abstract] [Full Text]  
  • Heinig, M. J., Francis, J., Pappagianis, D. (1999). Mammary Candidosis in Lactating Women. J Hum Lact 15: 281-288 [Abstract]  
  • Kuipers, M. E., de Vries, H. G., Eikelboom, M. C., Meijer, D. K. F., Swart, P. J. (1999). Synergistic Fungistatic Effects of Lactoferrin in Combination with Antifungal Drugs against Clinical Candida Isolates. Antimicrob. Agents Chemother. 43: 2635-2641 [Abstract] [Full Text]  
  • Wakabayashi, H., Matsumoto, H., Hashimoto, K., Teraguchi, S., Takase, M., Hayasawa, H. (1999). N-Acylated and D Enantiomer Derivatives of a Nonamer Core Peptide of Lactoferricin B Showing Improved Antimicrobial Activity. Antimicrob. Agents Chemother. 43: 1267-1269 [Abstract] [Full Text]  
  • Ha, K. C., White, T. C. (1999). Effects of Azole Antifungal Drugs on the Transition from Yeast Cells to Hyphae in Susceptible and Resistant Isolates of the Pathogenic Yeast Candida albicans. Antimicrob. Agents Chemother. 43: 763-768 [Abstract] [Full Text]